Gorman-Rupp rises 5.2% after quarterly results beat estimates and dividend hike

What happened

Gorman-Rupp (GRC) rose 5.2% on October 23, 2026, after quarterly results beat estimates and the company raised its quarterly dividend. The stock closed at $73.76 after opening 3.8% above the previous close, trading 2.7 times its 20-day average. The S&P 500 fell 0.5% on the day, and the Industrials sector median fell 0.4%, leaving the stock’s performance 5.6 percentage points better than the sector median.

The company reported record third-quarter 2026 results with net sales of $193.3 million, up 11.8% year-over-year, and record net income of $22.7 million, or $0.86 per share, according to Business Wire and Seeking Alpha. The $0.86 in reported earnings per share exceeded the $0.69 figure used in session comparisons. The board declared a quarterly cash dividend of $0.20 per share, payable December 10, 2026, a 5.3% increase from the prior quarter’s $0.19 per share, according to Business Wire.

How big was the move

The stock’s 5.2% gain was 3.0 times a typical daily move for this stock and came on volume 2.7 times its 20-day average, indicating a larger-than-normal, company-specific reaction. Over the last five sessions the stock rose 2.6%, while the S&P 500 fell 0.5% over the same span. Market sensitivity is modest, with a beta of 0.89, meaning the stock tends to move less than the market.

In the past five years the stock had 16 sessions with a gain of at least 5.2%. Twenty trading days later the median result was a gain of 1.6%, and 8 of 16 were higher. The session move was earnings-driven because the quarterly results were released that day.

The technical picture

Technically, the stock sat 0.4% below its 20-day moving average and 1.5% below its 50-day moving average. It was 2.5% above its 200-day moving average, and the 50-day average is above the 200-day average, a sign of an established uptrend. The Relative Strength Index (14 days) was 50, in a neutral range between 30 and 70.

The shares were 20.5% below the 52-week high. They had fallen 1.2% over one month and 8.4% over three months, but rose 53.1% over one year. That one-year gain left the stock 39.3 percentage points ahead of the S&P 500 over the same period. Volatility was 28% annualized over 60 days, lower than 67% of its own readings over five years.

Fundamentals and valuation

For the four quarters through September 30, 2026, Gorman-Rupp reported revenue of $722.5 million, which grew 6.5% from a year earlier and accelerated from revenue growth of 4.2% in the prior quarter. Diluted earnings per share for that period were $2.79, a rise of 46.1% year-over-year. Gross margin expanded to 32.1% from 29.9% a year earlier, and operating margin rose to 16.1% from 13.5%.

Free-cash-flow margin was 18.4% and return on invested capital was 10.3%, while the balance sheet showed net cash of $59.3 million. Share count increased by 0.5% over one year. The company’s market value was $1.90 billion at session close.

Valuation metrics included 26.4 times trailing earnings and 26.3 times expected forward earnings, with a free-cash-flow yield of 7.0%. The price to trailing earnings is lower than 71% of its own readings over the past five years, where the five-year median was 31.4 times earnings.

Earnings and analyst expectations

The October 23, 2026, report showed earnings per share of $0.86 against $0.69 expected in the session data, a 23.7% beat. That marked the fourth consecutive quarter beating estimates, and the average surprise over the last four reports was 20.3% above estimates. The typical two-day reaction after recent reports has been a rise of 4.6%.

Three analysts provide ratings, with 33% of them at Buy or Strong Buy and a consensus rating of Hold. The next scheduled earnings report is February 5, 2027.

What to watch

• February 5, 2027: Next reported earnings date.
• December 10, 2026: Dividend payable date for the $0.20 per share quarterly dividend declared October 23, 2026.
• One year change: revenue grew 6.5% for the four quarters through September 30, 2026, and diluted EPS rose 46.1%.
• Valuation context: price to trailing earnings is 26.4 times, lower than 71% of its own readings over five years.